Holoprosencephaly-postaxial polydactyly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2166OMIM:264480Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Holoprosencephaly-postaxial polydactyly syndrome (also known as pseudotrisomy 13 syndrome or holoprosencephaly-polydactyly syndrome) is an extremely rare congenital malformation syndrome characterized by the combination of holoprosencephaly (a failure of the forebrain to properly divide into two hemispheres) and postaxial polydactyly (extra digits on the outer side of the hands and/or feet). The condition primarily affects the central nervous system and the limbs, and may also involve craniofacial abnormalities such as midline facial defects (cyclopia, cebocephaly, median cleft lip, or hypotelorism), microcephaly, and other structural brain malformations. Cardiac defects and other visceral anomalies have also been reported in some cases. The clinical presentation overlaps significantly with trisomy 13 (Patau syndrome), but affected individuals have a normal karyotype, which is why the condition has been referred to as pseudotrisomy 13. The severity of holoprosencephaly can range from alobar (most severe) to lobar forms, and the prognosis is generally very poor, with most affected infants dying in the neonatal period or early infancy. The condition is typically identified prenatally or at birth based on the characteristic combination of brain and limb malformations. There is no specific curative treatment; management is supportive and symptomatic, focusing on comfort care and addressing individual medical complications as they arise. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hypoplasia of the premaxillaHP:0010650Adrenal hypoplasiaHP:0000835Abnormality of the hypothalamus-pituitary axisHP:0000864Abnormal lung lobationHP:0002101Thyroid hypoplasiaHP:0005990
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Holoprosencephaly-postaxial polydactyly syndrome.

View clinical trials →

No actively recruiting trials found for Holoprosencephaly-postaxial polydactyly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Holoprosencephaly-postaxial polydactyly syndrome community →

No specialists are currently listed for Holoprosencephaly-postaxial polydactyly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Holoprosencephaly-postaxial polydactyly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Holoprosencephaly-postaxial polydactyly syndromeForum →

No community posts yet. Be the first to share your experience with Holoprosencephaly-postaxial polydactyly syndrome.

Start the conversation →

Latest news about Holoprosencephaly-postaxial polydactyly syndrome

No recent news articles for Holoprosencephaly-postaxial polydactyly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Holoprosencephaly-postaxial polydactyly syndrome

What is Holoprosencephaly-postaxial polydactyly syndrome?

Holoprosencephaly-postaxial polydactyly syndrome (also known as pseudotrisomy 13 syndrome or holoprosencephaly-polydactyly syndrome) is an extremely rare congenital malformation syndrome characterized by the combination of holoprosencephaly (a failure of the forebrain to properly divide into two hemispheres) and postaxial polydactyly (extra digits on the outer side of the hands and/or feet). The condition primarily affects the central nervous system and the limbs, and may also involve craniofacial abnormalities such as midline facial defects (cyclopia, cebocephaly, median cleft lip, or hypotel

How is Holoprosencephaly-postaxial polydactyly syndrome inherited?

Holoprosencephaly-postaxial polydactyly syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Holoprosencephaly-postaxial polydactyly syndrome typically begin?

Typical onset of Holoprosencephaly-postaxial polydactyly syndrome is neonatal. Age of onset can vary across affected individuals.